ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImaginAb Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10870
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product portfolio includes fungicides, herbicides, and insecticides among others. Biomar’s pharmaceutical preclinical pipeline comprises compounds for cancer, glioblastoma, and infectious and autoimmune diseases. The company also offers services such as taxonomical identification, screening and active compound identification. The company is funded by Cycad Group, Raptor, and Nextech Invest Ltd among others. It has operation in the US and Japan. ImaginAb is headquartered in Inglewood, California, the US.

ImaginAb Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaginAb Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImaginAb Raises USD7.7 Million in Venture Financing 11
ImaginAb Raises USD5.3 Million in Financing 12
ImaginAb Raises USD21 Million in Series B Venture Financing 13
Partnerships 14
Eli Lilly Enters into Research Agreement with ImaginAb 14
ImaginAb Enters Into Co-Development Agreement With H. Lundbeck For CNS Imaging Biologics 15
ImaginAb Inc – Key Competitors 16
ImaginAb Inc – Key Employees 17
ImaginAb Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jun 22, 2018: Imagin Reconstitutes Japanese Subsidiary 19
May 17, 2018: ImaginAb Reconstitutes Scientific Advisory Board 20
Feb 06, 2018: ImaginAb Names Ian Wilson As Chief Operating Officer 21
Mar 22, 2017: ImaginAb Appoints Martyn Coombs as New Chief Executive Officer 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
ImaginAb Inc, Pharmaceuticals & Healthcare, Key Facts 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaginAb Raises USD7.7 Million in Venture Financing 11
ImaginAb Raises USD5.3 Million in Financing 12
ImaginAb Raises USD21 Million in Series B Venture Financing 13
Eli Lilly Enters into Research Agreement with ImaginAb 14
ImaginAb Enters Into Co-Development Agreement With H. Lundbeck For CNS Imaging Biologics 15
ImaginAb Inc, Key Competitors 16
ImaginAb Inc, Key Employees 17

List of Figures
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KNM Group Bhd (KNM):石油・ガス:M&Aディール及び事業提携情報
    Summary KNM Group Bhd (KNM Group) is a manufacturer of custom designed process equipment's and modular systems. The company's product portfolio includes gas waste heat recovery systems, process and pressure vessels, quench coolers, scraped surface exchangers, heat transfer equipment, membrane techno …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務分析
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, …
  • FleetPride, Inc.:企業のM&A・事業提携・投資動向
    FleetPride, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetPride, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • SciDev Ltd:企業の戦略・SWOT・財務情報
    SciDev Ltd - Strategy, SWOT and Corporate Finance Report Summary SciDev Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Spicers Ltd:企業の戦略的SWOT分析
    Spicers Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析
    Summary Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory co …
  • Thales USA, Inc.:戦略・SWOT・企業財務分析
    Thales USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thales USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shopper’S Stop Ltd.:企業の戦略・SWOT・財務分析
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Care Group:企業の製品パイプライン分析2018
    Summary Care Group India (Care Group) is a manufacturer and supplier of intraocular lens (IOLs) and ophthalmic surgical products. Its product portfolio includes cataract intraocular lens (IOLs) including hydrophilic, hydrophobic, polymethyl methacrylate (PMMA) models and implantable phakic contact l …
  • Synedgen Inc-医療機器分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務情報
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bear Creek Mining Corp (BCM):企業の財務・戦略的SWOT分析
    Summary Bear Creek Mining Corp (Bear Creek) is a silver exploration and development company. The company's projects include Santa Ana project and Corani project. Its Corani project located in the Andes Mountains of Peru and explores for silver, lead, zinc deposit. Bear Creek also conducts silver and …
  • WEC Energy Group Inc:企業の発電所・SWOT分析2018
    WEC Energy Group Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Swedbank AB:企業の戦略・SWOT・財務分析
    Swedbank AB - Strategy, SWOT and Corporate Finance Report Summary Swedbank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆